rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0078058,
umls-concept:C0085533,
umls-concept:C0175630,
umls-concept:C0392747,
umls-concept:C0441889,
umls-concept:C0443172,
umls-concept:C0664390,
umls-concept:C0746319,
umls-concept:C1256770
|
pubmed:issue |
2C
|
pubmed:dateCreated |
2006-4-18
|
pubmed:abstractText |
The goal of the present study was to investigate the changes in concentration of the important lymph-angiogenesis factors vascular endothelium-derived growth factor (VEGF) and VEGF-D under adjuvant chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
pubmed-author:BlohmerJens-UweJU,
pubmed-author:EggemannHolmH,
pubmed-author:EllingDirkD,
pubmed-author:EmonsGünterG,
pubmed-author:HeilmannVolkerV,
pubmed-author:JeschkeSophiaS,
pubmed-author:KümmelSherkoS,
pubmed-author:KoblMichaelM,
pubmed-author:KorlachSusanneS,
pubmed-author:LüftnerDianaD,
pubmed-author:SchmidPeterP,
pubmed-author:SehouliJalidJ,
pubmed-author:ThomasAnkeA,
pubmed-author:UlmKurtK,
pubmed-author:ZeiserTobiasT,
pubmed-author:ZerfelNadineN
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1719-26
|
pubmed:meshHeading |
pubmed-meshheading:16617567-Adult,
pubmed-meshheading:16617567-Aged,
pubmed-meshheading:16617567-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16617567-Breast Neoplasms,
pubmed-meshheading:16617567-Chemotherapy, Adjuvant,
pubmed-meshheading:16617567-Cyclophosphamide,
pubmed-meshheading:16617567-Epirubicin,
pubmed-meshheading:16617567-Female,
pubmed-meshheading:16617567-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:16617567-Humans,
pubmed-meshheading:16617567-Lymphatic Metastasis,
pubmed-meshheading:16617567-Middle Aged,
pubmed-meshheading:16617567-Paclitaxel,
pubmed-meshheading:16617567-Prospective Studies,
pubmed-meshheading:16617567-Vascular Endothelial Growth Factor A,
pubmed-meshheading:16617567-Vascular Endothelial Growth Factor D
|
pubmed:articleTitle |
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
|
pubmed:affiliation |
Department of Senology, University Medicine Berlin, Campus Charité Mitte, Berlin, Germany. sherko.kuemmel@charite.de
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III
|